Novartis shares down as failed cholesterol drug study increases pipeline pressure

HHimma Investments

NVDA 218.65 −3.1%TSLA 365.675 −0.7%AAPL 319.44 +1.3%GOOGL 329.84 −2.5%AMZN 252.275 −0.0%HOOD 114.07 −2.8%ENAUSD 0.180179MORPHOUSD 2.63ONDOUSD 0.375057 −0.6%PUMPUSD 0.0042852 +0.2%WLDUSD 0.489115 +19.1%TXGE 8388.76953 −1.7%MU 981.96 −1.8%SNDK 1698.695 −2.3%AVGO 363.435 −1.4%SPCX 150.45 −2.0%MSFT 491.42 −0.5%META 652.485 +6.4%DELL 517.98 −3.0%INTC 101.64 −2.7%AMD 507.54 −2.6%PLTR 167.01 −1.9%GOOG 327.455 −2.4%MRVL 230.59 +2.3%ORCL 158.405 −2.5%TSM 431.44 −1.7%LITE 958.69 −2.0%CRM 245.505 −1.5%BE 266.01 −1.2%MSTR 130.16 −4.7%SNOW 333.175 −0.7%NBIS 229.605 −5.9%AMAT 457.59 −2.4%SKHY 192.85 +3.9%PANW 341.57 +1.4%LLY 1128.155 +0.4%STX 855.79 −5.4%CRDO 163.41 −2.6%WDC 461.95 −3.2%WMT 105.97 −0.1%MRNA 134.28 −4.3%CRWD 212.76 +2.4%LRCX 302.74 −5.5%NFLX 76.025 −1.0%HPE 56.385 +0.6%CRWV 90.75009918 −9.1%NOW 133.785 −0.3%WBS 77.57 0.0%XOM 165.055 +2.7%ASML 1704.86 −3.4%09/10/2026, 11:57 ET · STALE · coingecko,twelve_data,twelve_data_websocket

FILTERS · MARKET · SCORE 5

COVERAGE

My names Portfolio only Market-wide

MIN SCORE

All ≥5 ≥7 ≥9